Emcure Pharmaceuticals Ltd.
EMCURE
Classement en actions
#4306
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Prix de l'action
$19.06
Capitalisation boursière
$3.62B
Changement (1 jour)
-1.83%
Changement (1 an)
20.50%
Pays
IN
Échange Emcure Pharmaceuticals Ltd. (EMCURE)
Catégorie
Healthcare
Historique du rendement du dividende pour Emcure Pharmaceuticals Ltd. (EMCURE)
Le rendement du dividende (TTM) de Emcure Pharmaceuticals Ltd. (symbole boursier : EMCURE) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Emcure Pharmaceuticals Ltd. (EMCURE) de 2025 à 2026
Rendement du dividende à la fin de chaque année (TTM)
| Année | Rendement du dividende | Changez |
|---|---|---|
| 2025 | 0.00% | 0.00% |
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
| Entreprise | Rendement du dividende | Pays |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
